Ulthera, which makes an ultrasound device designed to lift lax tissue on the neck and under the chin, registers for an initial public offering worth up to $86 million. Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange. Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body's natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.
Help employers find you! Check out all the jobs and post your resume.
